Gokhan Ozuner, MD
Colon & Rectal Surgery · Brooklyn, NYNPI 1093723843
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $1,453 of the $2,176 with a category attached, or 66.7%. 8 manufacturers reported payments, led by Medtronic at 50.3% of the total. Reporting peaked in 2021 at $833 and has fallen 62.0% since, to $317 in 2024.
Across 12 payments — averaging $181.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$1K
- Covidien LP$600
- Aroa Biosurgery Incorporated$195
- Shire North American Group Inc$125
- Stryker$68
- Medical Device Business Services, Inc.$58
- plus $35 from 2 others
What the payments were for
- Consulting fees$1,45367%
- Food & beverage$72433%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 4 | $1,095 |
| Covidien LP | 1 | $600 |
| Aroa Biosurgery Incorporated | 1 | $195 |
| Shire North American Group Inc | 2 | $125 |
| Stryker | 1 | $68 |
| Medical Device Business Services, Inc. | 1 | $58 |
| Trevena, Inc. | 1 | $21 |
| Johnson & Johnson | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,176 in reported general payments places this provider in the 55th percentile of 177 colon & rectal surgery providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Peg-3350 And ElectrolytesPeg3350/Sod Sulf,bicarb,cl/Kcl | 19 | $291 |
Paid to pharmacies, not to this prescriber.
Other colon & rectal surgery in Brooklyn
- Josef ShehebarBrooklyn$13K
- Henry TalusBrooklyn$10K
- Mychailo FulmesBrooklyn$8K
- Hans BurkholderBrooklyn$6K
- David RivadeneiraWoodbury$271K
- Jerald WishnerMount Kisco$246K
- Sanghyun KimNew York$154K
- Ziad KronfolWest Nyack$81K
- Lynn OconnorHuntington$63K
- Mehraneh JafariNew York$50K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.